Ensign Peak Advisors’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
Other funds holding MD
WA
Ensign Peak Advisors's MD Position: Q2 2026 in Review
Ensign Peak Advisors reduced its Pediatrix Medical (MD) stake by 8.2% in Q2 2026, selling an estimated $14.8K and leaving 7,254 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.
Ensign Peak Advisors first reported a position in MD in Q4 2019 and has held it in 27 quarters since. The position peaked at $11.9M in Q4 2019. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.
- Ensign Peak Advisors held 7,254 shares of Pediatrix Medical worth $184K as of Q2 2026.
- Ensign Peak Advisors sold 650 Pediatrix Medical shares in Q2 2026, an estimated $14.8K.
- Pediatrix Medical made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1423 holding.
- Ensign Peak Advisors first reported a position in Pediatrix Medical in Q4 2019 and has held it in 27 quarters since.
- Ensign Peak Advisors's Pediatrix Medical position peaked at $11.9M in Q4 2019.
- 305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.
Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.